10x Genomics, Inc. Class A Common Stock
TXG Real Time Price USDRecent trades of TXG by members of U.S. Congress
---
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in TXG holdings by institutional investors
Quarterly net insider trading by TXG's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More about Alpha -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More about Annual Standard Deviation -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More about Annual Volatility -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More about Beta -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More about CAGR -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More about Information Ratio -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More about Max Drawdown -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More about Sharpe Ratio -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More about Treynor Ratio -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$80,000 Feb 07, 2024 Issue: Health Issues
-
$40,000 Jan 20, 2024 Issue: Health Issues
-
$80,000 Oct 17, 2023 Issue: Health Issues
-
$80,000 Jul 17, 2023 Issue: Health Issues
-
$80,000 Oct 19, 2022 Issue: Health Issues
-
$80,000 Jul 19, 2022 Issue: Health Issues
-
$80,000 Apr 13, 2022 Issue: Health Issues
-
$80,000 Jan 19, 2022 Issue: Health Issues
-
$80,000 Oct 18, 2021 Issue: Health Issues
-
$80,000 Jul 19, 2021 Issue: Health Issues
-
$80,000 Apr 18, 2021 Issue: Health Issues
-
$80,000 Jan 18, 2021 Issue: Health Issues
-
$10,000 Oct 20, 2020 Issue: Taxation/Internal Revenue Code
-
$10,000 Jul 24, 2020 Issue: Taxation/Internal Revenue Code
Former government officials who have lobbied for TXG
12 former government officials from 6 congressional offices at 2 lobbying firms have lobbied for TXG, most recently Feb 07, 2024.
-
Raissa Downs Senate Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
-
Jennifer Young Congress Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance
-
Michelle Easton Congress Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
-
Elizabeth Murray House Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham -
Charlotte Ivancic Senate Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner -
Pamela Smith Senate Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept. of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Senator Carol Moseley-Braun -
Emily Murry House Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price
-
Kimberly Brandt Senate Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance
TXG Estimated quarterly lobbying spending
TXG Revenue by Segment or Geography
New TXG patent grants
Federal grants, loans, and purchases
- $24,980 2026-09-29 00:00:00 Agency: Department of Health and Human Services
- $300,590 2026-09-28 00:00:00 Agency: Department of Health and Human Services
- $199,330 2026-09-28 00:00:00 Agency: Department of Veterans Affairs
- $52,764 2026-09-23 00:00:00 Agency: Department of Health and Human Services
- $94,822 2026-09-23 00:00:00 Agency: Department of Health and Human Services
- $249,990 2026-09-22 00:00:00 Agency: Department of Health and Human Services
- $45,823 2026-09-22 00:00:00 Agency: Department of Veterans Affairs
- $119,915 2026-09-21 00:00:00 Agency: Department of Health and Human Services
- $36,704 2026-09-18 00:00:00 Agency: Department of Health and Human Services
- $59,611 2026-09-18 00:00:00 Agency: Department of Health and Human Services
- $37,710 2026-09-16 00:00:00 Agency: Department of Veterans Affairs
- $52,580 2026-09-14 00:00:00 Agency: Department of Health and Human Services
- $45,840 2026-09-14 00:00:00 Agency: Department of Health and Human Services
- $37,164 2026-09-08 00:00:00 Agency: Department of Health and Human Services
- $559,550 2026-08-27 00:00:00 Agency: Department of Health and Human Services
- $42,541 2026-08-25 00:00:00 Agency: Department of Veterans Affairs
- $21,423 2026-08-21 00:00:00 Agency: Department of Health and Human Services
- $64,354 2026-08-20 00:00:00 Agency: Department of Health and Human Services
- $49,856 2026-08-12 00:00:00 Agency: Department of Health and Human Services
- $49,657 2026-08-10 00:00:00 Agency: Department of Health and Human Services
- $38,500 2026-08-10 00:00:00 Agency: Department of Health and Human Services
- $34,600 2026-08-05 00:00:00 Agency: Department of Veterans Affairs
- $127,092 2026-08-05 00:00:00 Agency: Department of Agriculture
- $0 2026-08-04 00:00:00 Agency: Department of Veterans Affairs
- $133,530 2026-08-04 00:00:00 Agency: Department of Agriculture
- $10,840 2026-07-28 00:00:00 Agency: Department of Veterans Affairs
- $19,899 2026-07-22 00:00:00 Agency: Department of Health and Human Services
- $42,808 2026-07-15 00:00:00 Agency: Department of Health and Human Services
- $42,808 2026-07-15 00:00:00 Agency: Department of Health and Human Services
- $349,999 2026-06-15 00:00:00 Agency: Department of Veterans Affairs
- $41,000 2026-06-11 00:00:00 Agency: Department of Veterans Affairs
- $38,500 2026-05-05 00:00:00 Agency: Department of Health and Human Services
- $39,407 2026-04-15 00:00:00 Agency: Department of Veterans Affairs
- $22,586 2026-02-18 00:00:00 Agency: Department of Health and Human Services
- $21,315 2026-01-29 00:00:00 Agency: Department of Health and Human Services
- $24,999 2026-01-23 00:00:00 Agency: Department of Health and Human Services
- $17,000 2026-01-07 00:00:00 Agency: Department of Health and Human Services
- $22,420 2025-12-11 00:00:00 Agency: Department of Health and Human Services
- $87,710 2025-09-29 00:00:00 Agency: Department of Health and Human Services
- $94,699 2025-09-28 00:00:00 Agency: Department of Health and Human Services
- $249,964 2025-09-28 00:00:00 Agency: Department of Health and Human Services
- $89,198 2025-09-28 00:00:00 Agency: Department of Health and Human Services
- $97,408 2025-09-26 00:00:00 Agency: Department of Health and Human Services
- $249,991 2025-09-26 00:00:00 Agency: Department of Health and Human Services
- $137,739 2025-09-26 00:00:00 Agency: Department of Health and Human Services
- $14,849 2025-09-25 00:00:00 Agency: Department of Health and Human Services
- $246,535 2025-09-25 00:00:00 Agency: Department of Health and Human Services
- $43,673 2025-09-24 00:00:00 Agency: Department of Health and Human Services
- $24,849 2025-09-24 00:00:00 Agency: Department of Health and Human Services
- $249,785 2025-09-24 00:00:00 Agency: Department of Health and Human Services
Estimated quarterly amount awarded to TXG from public contracts
Recent insights relating to TXG
Pending bills that may affect TXG
|
Bill
|
Impact
|
Confidence
|
Date
|
|---|
Recent picks made for TXG stock on CNBC
ETFs with the largest estimated holdings in TXG
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $TXG stock a Buy, Sell, or Hold?
- What is the price target for $TXG stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $TXG stock?
- Who owns the most shares of $TXG stock?
- What funds own $TXG stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TXG Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
- Address Pleasanton, CA
- Market Cap 7.7 billion
- Employees 1,178
- Industrial Classification Laboratory Analytical Instruments
10x Genomics, Inc. Class A Common Stock (TXG) Historical Stock Prices
Daily open, high, low, close, adjusted close and volume for 10x Genomics, Inc. Class A Common Stock (TXG).
Quiver Premium charts TXG's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.
Upgrade to Premium| Date | Open | High | Low | Close | Adj. Close | Volume |
|---|
Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.
The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.
Explore the Quiver APIWe estimate that -- received a compensation of -- in --, making them the highest paid executive at TXG, per a recent SEC DEF 14A filing. We estimate that the median employee at 10x Genomics, Inc. is paid $205,000.
|
Name
|
Role
|
Salary
|
Bonus
|
Stock/Option Awards
|
Total Compensation
|
|---|